Literature DB >> 12495279

Impact of volume control on left ventricular hypertrophy in dialysis patients.

Mehmet Ozkahya1, Huseyin Toz, Filiz Qzerkan, Soner Duman, Ercan Ok, Ali Basci, Evert J Dorhout Mees.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH), which strongly predicts cardiac mortality, is seen in more than 60% of end-stage renal disease patients. The aim of this study was to prospectively investigate the effect of salt restriction and strict volume control on blood pressure and LVH.
METHOD: Nineteen hypertensive patients on chronic hemodialysis (HD) treatment (age 52 +/- 17 years, 7 women) were included in the study. Treatment consisted of 12-h HD per week, during which as much ultrafiltration (UF) was applied as possible without an excessive blood pressure (BP) drop. Special attention was given to dietary salt restriction. Predialysis mean BP (MBP), body weight (BW), cardio-thoracic index (CTI) and echocardiographic results were recorded at baseline and after 6 and 12 months.
RESULTS: All patients reached acceptable BP (< 140/90 mmHg) within three months (10-75 days) with our strict volume control strategy. Mean pre-dialysis BP was 127 +/- 17/78 +/- 9 mm Hg at baseline, 120 +/- 9/75 +/- 6 mm Hg at the 6th month and 118 +/- 11/73 +/- 5 mm Hgat the 12th month. The incidence of symptomatic hypotension gradually decreased from a mean of 22% to 11% and 7%, respectively during follow-up. Left ventricular mass index decreased from 164 +/- 64 to 112 +/- 36 g/m2. CTI, left atrial, left ventricular systolic and diastolic diameters significantly decreased in all patients. Inter-dialytic weight gain was 930 +/- 70 g/day in the follow-up period. Hematocrit did not significantly differ at the first, second and last visits.
CONCLUSION: Normal BP and improvement of cardiac structure, in particular a reduction of LVH could be reached in all our patients by intensifying salt restriction and UF.

Entities:  

Mesh:

Year:  2002        PMID: 12495279

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  22 in total

1.  Probing dry-weight improves left ventricular mass index.

Authors:  Rajiv Agarwal; J Michael Bouldin; Robert P Light; Ashok Garg
Journal:  Am J Nephrol       Date:  2010-12-13       Impact factor: 3.754

Review 2.  Setting the dry weight and its cardiovascular implications.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

3.  Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes.

Authors:  Chen Huan-Sheng; Chang Yeong-Chang; Hsieh Ming-Hsing; Tseng Fan-Lieh; Lin Chu-Cheng; Wu Tsai-Kun; Chen Hung-Ping; Hung Sze-Hung; Chiu Hsien-Chang; Lee Chia-Chen; Hou Chun-Cheng; Cheng Chun-Ting; Liou Hung-Hsiang; Lin Chun-Ju; Lim Paik-Seong
Journal:  Int Urol Nephrol       Date:  2016-09-12       Impact factor: 2.370

Review 4.  Antihypertensive Agents in the Dialysis Patient.

Authors:  Michelle A Fravel; Elizabeth Bald; Mony Fraer
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

5.  Reduction of left ventricular hypertrophy in children undergoing hemodialysis.

Authors:  Tim Ulinski; Julie Genty; Christine Viau; Isabelle Tillous-Borde; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

6.  Extracellular fluid management and hypertension in urban dwelling versus rural dwelling hemodialysis patients.

Authors:  Marcello Tonelli; Anita Lloyd; Neesh Pannu; Scott Klarenbach; Pietro Ravani; Kailash Jindal; Jennifer MacRae; Larry Unsworth; Braden Manns; Brenda Hemmelgarn
Journal:  J Nephrol       Date:  2016-08-23       Impact factor: 3.902

Review 7.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

8.  Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis.

Authors:  Geoffrey A Block; David P Rosenbaum; Maria Leonsson-Zachrisson; Bergur V Stefansson; Tina Rydén-Bergsten; Peter J Greasley; Susanne A Johansson; Mikael Knutsson; Björn C Carlsson
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

9.  Psychometric Validation of the Self-Efficacy for Restricting Dietary Salt in Hemodialysis Scale.

Authors:  Maya N Clark-Cutaia; Dianxu Ren; Leslie A Hoffman; Linda Snetselaar; Mary Ann Sevick
Journal:  Top Clin Nutr       Date:  2013 Oct-Dec       Impact factor: 0.508

10.  A PDA-based dietary self-monitoring intervention to reduce sodium intake in an in-center hemodialysis patient.

Authors:  Mary Ann Sevick; Roslyn A Stone; Matthew Novak; Beth Piraino; Linda Snetselaar; Rita M Marsh; Beth Hall; Heather Lash; Judith Bernardini; Lora E Burke
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.